The company didn't specify any timelines on when the drug will be available in India, or whether it has initiated any discussions with the government or the Central Drugs Standard Control Organisation (CDSCO) for launch of the drug.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3KhTIat
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» GSK to increase Covid drug capacity, but no plans for India yet
https://ift.tt/eA8V8J
No comments:
Post a Comment